step 1 semaglutide 2.4 mg weight loss percent Efficacy and safety of by race and ethnicity: A post hoc analysis of three randomized controlled trials - Rubino - 2024 - Obesity Semaglutide, a glucagon-like peptide-1 (GLP-1)

Doctors warn that GLP-1s can cause muscle loss in addition to fat loss

According to the 2023 "Report on the Nutritional and Chronic Disease Status of Chinese Residents," as of 2023, the population of overweight and obese individuals in China has exceeded 530 million, making China the country with the highest number of obese people globally

Huang Q, Liu Z, Yang Y, Yang Y, Huang T, Hong Y, et al

Average Blood Pressure Reductions Seen in Studies These improvements may seem small, but they can have important cardiovascular implications

Budget-Friendly Alternatives: Microdose Protocol and Combination Options PlexusDx microdose GLP-1 protocol starts at just $129 per month, making it the most affordable entry point for weight loss treatment

Schedule your free consultation today and take the first step toward real results.